CFLAR and prostate cancer: Increased expression of c-FLIP has been detected in many human malignancies, including melanoma, hepatocellular carcinoma [40], nonsmall cell lung carcinoma [40], and endometrial [41], colon [42], and prostate cancer [43–45].